Cargando…
Almotriptan in the acute treatment of migraine in patients 11–17 years old: an open–label pilot study of efficacy and safety
The objective was to investigate the safety and efficacy of almotriptan in patients aged 11–17 years old with acute migraine. Fifteen patients aged 11–17 with a history of migraine with or without aura were treated with almotriptan. Reduction in headache severity, disability and adverse effects were...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3451700/ https://www.ncbi.nlm.nih.gov/pubmed/16688412 http://dx.doi.org/10.1007/s10194-006-0288-0 |